查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
密蘇裡州醫用大麻市場規模、份額、趨勢分析：產品（花、油/酊劑）、應用（慢性疼痛、抽動穢語綜合徵）、分部預測，2022-2030
市場調查報告書
商品編碼
1097060

密蘇裡州醫用大麻市場規模、份額、趨勢分析：產品（花、油/酊劑）、應用（慢性疼痛、抽動穢語綜合徵）、分部預測，2022-2030

Missouri Medical Cannabis Market Size, Share & Trends Analysis Report By Product (Flower, Oils & Tinctures), By Application (Chronic Pain, Tourette's), And Segment Forecasts, 2022 - 2030
出版日期: | 出版商: Grand View Research | 英文 80 Pages | 商品交期: 2-10個工作天內

價格

密蘇裡州醫用大麻市場增長和趨勢

根據 Grand View Research, Inc. 的最新報告，密蘇裡州的醫用大麻市場預計到 2030 年將達到 20.2 億美元。

從 2022 年到 2030 年，CAGR 預計將增長 22.7%。越來越多的大麻健康益處證據、患者對這些益處的了解增加以及慢性病患病率增加是市場增長的關鍵驅動力。此外，自 2018 年 11 月以來，密蘇裡州已獲得醫用大麻種植、加工、製造和分銷的許可。從那時起，醫用大麻的銷量猛增，推動了該州的增長。

從應用來看，由於患者數量眾多，慢性疼痛領域佔有絕對優勢，2021年市場份額超過25.0%。慢性疼痛包括神經源性問題、關節炎、腰痛、癌症、頭痛、頸部問題和麵部問題。據說醫用大麻可以拯救遭受痛苦的人。隨著越來越多的人了解攝入大麻產品的重要性和益處，預計該市場將在預測期內增長。

按產品劃分，油酊劑佔 2021 年收益的最大份額。該細分市場增長的關鍵因素包括使用油和酊劑而不是花煙熏帶來的好處和易用性。由於接受諸如創傷後應激障礙、癲癇、自閉症和慢性疼痛等健康狀況治療的患者的需求增加，預計該部分在預測期內將以最快的速度增長。

幾乎在所有企業中，COVID-19 大流行導致大規模倒閉，擾亂日常運營並影響消費者行為。由於對 COVID-19 的反對增加，該零售店已關閉。由於中國、印度等主要原材料生產國物流停工，市場開始出現供應短缺現象。此外，美國各地的供應鏈中斷給額外原材料的供應帶來了沉重負擔，限制了市場增長。它還影響了大麻產品的生產，擾亂了該州的醫用大麻供應鏈。

密蘇裡州醫用大麻市場報告亮點

  • 醫用大麻的合法化和資質的提高可能會推動密蘇裡州的市場增長。
  • 受大麻提取物需求增加、用於治療各種慢性病的大麻合法化、大麻提取物產品新□□上市等因素影響，2021年油和酊劑產品領域將超過50.0%。獲得的收入份額和主導市場
  • 按應用來看，2021 年慢性疼痛以超過 25.0% 的收入份額引領市場。這是由於藥用大麻因其脫敏和抗炎特性而越來越多地用作急性疼痛的有效治療方法。

目錄

第一章調查方法及範圍

  • 調查方法
  • 調查範圍和先決條件
  • 數據源列表

第2章執行摘要

  • 市場展望

第 3 章密蘇裡州醫用大麻市場的變量、趨勢和範圍

  • 市場細分
  • 密蘇裡州醫用大麻市場動態
    • 市場促進因素分析
    • 市場製約因素分析
  • 滲透率和增長前景映射
  • 密蘇裡州醫用大麻市場分析工具
    • 密蘇裡州醫用大麻市場 PESTLE 分析
      • 政治和法律狀況
      • 環境狀況
      • 社會狀況
      • 技術情況
    • 行業分析-波特
      • 供應商實力：中等
      • 買方議價能力：低
      • 替代威脅：低
      • 來自新進入者的威脅：中
      • 競爭對手之間的敵對關係：略高
    • 監管場景
    • 市場機會分析
    • COVID-19 對市場的影響

第 4 章密蘇裡州醫用大麻市場：產品估計和趨勢分析

  • 密蘇裡州醫用大麻市場：產品波動分析
  • 花
    • 2018-2030 年花卉市場估計/預測（100 萬美元）
  • 油/酊劑
    • 2018-2030 年石油和酊劑市場估計和預測（100 萬美元）

第 5 章密蘇裡州醫用大麻市場：使用估計和趨勢分析

  • 密蘇裡州醫用大麻市場：使用波動分析
  • 癌症
    • 2018-2030 年癌症市場估計/預測（100 萬美元）
  • 慢性疼痛
    • 2018-2030 年慢性疼痛市場估計/預測（100 萬美元）
  • 抑鬱和焦慮
    • 2018-2030 年抑鬱症和焦慮症的市場估計和預測（100 萬美元）
  • 關節炎
    • 2018-2030 年關節炎市場估計/預測（100 萬美元）
  • 糖尿病
    • 2018-2030 年糖尿病市場估計和預測（100 萬美元）
  • 青光眼
    • 2018-2030 年青光眼市場估計和預測（100 萬美元）
  • 偏頭痛
    • 2018-2030 年偏頭痛市場估計和預測（100 萬美元）
  • 癲癇
    • 2018-2030 年癲癇市場估計/預測（100 萬美元）
  • 多發性硬化症
    • 2018-2030 年多發性硬化症市場估計和預測（100 萬美元）
  • 艾滋病
    • 2018-2030 年艾滋病市場估計和預測（100 萬美元）
  • 肌萎縮側索硬化症
    • 2018-2030 年肌萎縮側索硬化症市場估計和預測（100 萬美元）
  • 阿爾茨海默病
    • 2018-2030 年阿爾茨海默病市場估計和預測（100 萬美元）
  • 創傷後應激障礙
    • 2018-2030 年創傷後應激障礙市場估計和預測（100 萬美元）
  • 帕金森病
    • 2018-2030 年帕金森病市場估計和預測（100 萬美元）
  • 抽動穢語綜合徵
    • 2018-2030 年妥瑞氏綜合症市場估計和預測（100 萬美元）
  • 其他
    • 2018-2030 年其他市場估計/預測（100 萬美元）

第6章競爭態勢

  • 公司簡介
      • BeLeaf 醫療
        • 公司簡介
        • 財務表現
        • 戰略舉措
      • 藍鼠尾草大麻公司。
        • 公司簡介
        • 財務表現
        • 戰略舉措
      • 顯示替代方案
        • 公司簡介
        • 財務表現
        • 戰略舉措
      • 禾雅養生
        • 公司簡介
        • 財務表現
        • 戰略舉措
      • 密蘇裡狂野煉金術
        • 公司簡介
        • 財務表現
        • 戰略舉措
      • 有機療法
        • 公司簡介
        • 財務表現
        • 戰略舉措
      • 整體產業
        • 公司簡介
        • 財務表現
        • 戰略舉措
      • 堪薩斯城大麻
        • 公司簡介
        • 財務表現
        • 戰略舉措
      • 當地大麻公司
        • 公司簡介
        • 財務表現
        • 戰略舉措
      • MOcann 提取物
        • 公司簡介
        • 財務表現
        • 戰略舉措
Product Code: GVR-3-68038-978-4

Missouri Medical Cannabis Market Growth & Trends:

The Missouri medical cannabis market size is expected to reach USD 2.02 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 22.7% from 2022 to 2030. Growing evidence of marijuana's health advantages, rising patient knowledge regarding these benefits, and an increase in the prevalence of chronic conditions are the major factors contributing to the market growth. In addition, since November 2018, Missouri has allowed the cultivation, processing, manufacturing, and distribution of medical cannabis. Since then, a sharp rise has been witnessed in the sales of medical cannabis, thereby impelling the growth in the state.

Based on application, the chronic pain segment dominated the market in 2021 with a share of over 25.0% owing to a large patient pool. Pains associated with neurogenic issues, arthritis, low back issues, cancer, headache, neck-related issues, and face-related issues are just a few of the several types of chronic pain. Medical marijuana has been said to help people who are suffering from pain. The market is likely to witness growth during the forecast period as a growing number of people are understanding the importance and benefits of the intake of cannabis-based products.

Based on product, the oils and tinctures segment accounted for the largest revenue share in 2021. Some of the major factors responsible for the segment growth are benefits provided by the utilization of oils and tinctures over smoking flowers and ease of use. In addition, this segment is anticipated to grow at the fastest rate during the forecast period owing to its increasing demand from patients undergoing treatment for health conditions such as PTSD, epilepsy, autism, and chronic pain.

In practically every business, the COVID-19 pandemic has resulted in massive lockdowns, disrupting daily operations and affecting consumer behavior. Retail stores have been closed as the backlash to COVID-19 grows. Due to the suspension of the logistics industry in major raw material-producing countries such as China and India, the market began to experience a supply deficit. Furthermore, supply chain interruptions across the U.S. has led to a tremendous strain on the supply of additional raw materials, thereby constraining the market growth. In addition, this has impacted the manufacturing of cannabis products, and hence the supply chain for medical cannabis in the state has been disrupted.

Missouri Medical Cannabis Market Report Highlights:

  • The legalization of marijuana for medical purposes and the increasing number of people who qualify are likely to bolster the market growth in Missouri
  • Due to factors such as the rising demand for cannabis extracts, the legalization of marijuana for the treatment of various chronic diseases, and new cannabis extract product launches, the oil and tinctures product segment dominated the market in 2021 with a revenue share of over 50.0%
  • By application, chronic pain led the market with a revenue share of over 25.0% in 2021. This is due to a growth in the use of medicinal cannabis as an efficient therapy for acute pain owing to its ability to dull the perceptions and anti-inflammatory qualities

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Research Methodology
  • 1.2 Research Scope and Assumptions
  • 1.3 List to Data Sources

Chapter 2 Executive Summary

  • 2.1 Market Outlook

Chapter 3 Missouri Medical Cannabis Market Variables, Trends & Scope

  • 3.1 Market Segmentation
  • 3.2 Missouri Medical Cannabis Market Dynamics
    • 3.2.1 Market Driver Analysis
    • 3.2.2 Market Restraint Analysis
  • 3.3 Penetration & Growth Prospects Mapping
  • 3.4 Missouri Medical Cannabis Market Analysis Tools
    • 3.4.1 Missouri Medical Cannabis Market - PESTLE Analysis
      • 3.4.1.1 Political & Legal Landscape
      • 3.4.1.2 Environmental Landscape
      • 3.4.1.3 Social Landscape
      • 3.4.1.4 Technology Landscape
    • 3.4.2 Industry Analysis - Porter's
      • 3.4.2.1 Supplier Power: Moderate
      • 3.4.2.2 Buyer Power: Low
      • 3.4.2.3 Substitution Threat: Low
      • 3.4.2.4 Threat from New Entrants: Moderate
      • 3.4.2.5 Competitive Rivalry: Moderately High
    • 3.4.3 Regulatory Scenario
    • 3.4.4 Opportunity Analysis
    • 3.4.4 Impact of COVID-19 on the market

Chapter 4 Missouri Medical Cannabis Market: Product Estimates & Trend Analysis

  • 4.1 Missouri Medical Cannabis Market: Product Movement Analysis
  • 4.2 Flower
    • 4.2.1 Flower Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.3 Oils and Tinctures
    • 4.3.1 Oils & Tinctures Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5 Missouri Medical Cannabis Market: Application Estimates & Trend Analysis

  • 5.1 Missouri Medical Cannabis Market: Application Movement Analysis
  • 5.2 Cancer
    • 5.2.1 Cancer Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.3 Chronic Pain
    • 5.3.1 Chronic Pain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4 Depression & Anxiety
    • 5.4.1 Depression & Anxiety Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5 Arthritis
    • 5.5.1 Arthritis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6 Diabetes
    • 5.6.1 Diabetes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7 Glaucoma
    • 5.7.1 Glaucoma Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8 Migraines
    • 5.8.1 Migraines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.9 Epilepsy
    • 5.9.1 Epilepsy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.10 Multiple Sclerosis
    • 5.10.1 Multiple Sclerosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.11 AIDS
    • 5.11.1 AIDS Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.12 Amyotrophic Lateral Sclerosis
    • 5.12.1 Amyotrophic Lateral Sclerosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.13 Alzheimer's Disease
    • 5.13.1 Alzheimer's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.14 Post-Traumatic Stress Disorder
    • 5.14.1 Post-Traumatic Stress Disorder Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.15 Parkinson's Disease
    • 5.15.1 Parkinson's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.16 Tourette's Syndrome
    • 5.16.1 Tourette's Syndrome Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.17 Others
    • 5.17.1 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6 Competitive Landscape

  • 6.1 Company Profiles
    • 6.1.1 BeLeaf Medical
      • 6.1.1.1 Company overview
      • 6.1.1.2 Financial performance
      • 6.1.1.3 Strategic initiatives
    • 6.1.2 . Blue Sage Cannabis Co.
      • 6.1.2.1 Company overview
      • 6.1.2.2 Financial performance
      • 6.1.2.3 Strategic Initiatives
    • 6.1.3 Show Me Alternatives
      • 6.1.3.1 Company overview
      • 6.1.3.2 Financial performance
      • 6.1.3.3 Strategic Initiatives
    • 6.1.4 Heya Wellness
      • 6.1.4.1 Company overview
      • 6.1.4.2 Financial performance
      • 6.1.4.3 Strategic Initiatives
    • 6.1.5 Missouri Wild Alchemy
      • 6.1.5.1 Company overview
      • 6.1.5.2 Financial performance
      • 6.1.5.3 Strategic Initiatives
    • 6.1.6 Organic Remedies
      • 6.1.6.1 Company overview
      • 6.1.6.2 Financial performance
      • 6.1.6.3 Strategic Initiatives
    • 6.1.7 Holistic Industries
      • 6.1.7.1 Company overview
      • 6.1.7.2 Financial performance
      • 6.1.7.3 Strategic Initiatives
    • 6.1.8 Kansas City Cannabis
      • 6.1.8.1 Company overview
      • 6.1.8.2 Financial performance
      • 6.1.8.3 Strategic Initiatives
    • 6.1.9 LOCAL CANNABIS COMPANY
      • 6.1.9.1 Company overview
      • 6.1.9.2 Financial performance
      • 6.1.9.3 Strategic Initiatives
    • 6.1.10 MOcann Extracts
      • 6.1.10.1 Company overview
      • 6.1.10.2 Financial performance
      • 6.1.10.3 Strategic Initiatives

List of Tables

  • Table. 1 Missouri medical cannabis market, by product, 2018 - 2030 (USD Million)
  • Table. 2 Missouri medical cannabis market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Missouri medical cannabis market snapshot, 2021 (USD Million)
  • Fig. 2 Missouri medical cannabis market segmentation
  • Fig. 3 Missouri medical cannabis market dynamics
  • Fig. 4 Missouri medical cannabis market driver impact
  • Fig. 5 Missouri medical cannabis market restraints impact
  • Fig. 6 Penetration & growth prospects mapping for medical cannabis
  • Fig. 7 Missouri medical cannabis market: Opportunity analysis
  • Fig. 8 Missouri medical cannabis market, Product outlook: Key takeaways
  • Fig. 9 Missouri medical cannabis market: Product movement analysis (2021 & 2030) (USD Million)
  • Fig. 10 Flower market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 11 Oils & Tinctures market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 12 Missouri medical cannabis market, application outlook: Key takeaways
  • Fig. 13 Missouri medical cannabis market: application movement analysis (2021 & 2030)
  • Fig. 14 Cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 15 Chronic pain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 16 Depression & Anxiety market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 17 Arthritis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 Diabetes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Glaucoma market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Migraines market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Epilepsy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Multiple Sclerosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 AIDS market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Amyotrophic Lateral Sclerosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Alzheimer's Disease market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Post-Traumatic Stress Disorder market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Parkinson's Disease market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Tourette's Syndrome market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Others market estimates and forecasts, 2018 - 2030 (USD Million)